
Sarepta Therapeutics
Biotechnology • Cambridge, MA
About Sarepta Therapeutics
Sarepta Therapeutics is a commercial-stage biopharmaceutical company focused on precision genetic medicine for rare diseases. It develops RNA-targeted therapies, gene therapies, and gene-editing treatments. Its marketed products include the Duchenne muscular dystrophy therapies EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS.


